Bantam Pharmaceutical, LLC — Form D
Bantam Pharmaceutical, LLC of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2015-08-11. The offering totals $8.0M, of which $7.0M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2015-08-11
- Form: D
- Accession: 0001650608-15-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $8.0M
- Amount sold: $7.0M
- Remaining: $1.0M
- Minimum investment: $500K
- Investors: 5
- Date of first sale: 2015-07-13
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-245501
Issuer
- Name: Bantam Pharmaceutical, LLC
- CIK: 0001650608
- Entity type: Limited Liability Company
- Jurisdiction: DELAWARE
- Incorporated: 2015
- Address: 424 WEST 33RD STREET, NEW YORK, NY, 10001
- Phone: 212-631-0202
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Lionel F Goldfrank, III | Director | New York, NY |
| Victor F Keen | Director | New York, NY |
| W. James F Tozer, Jr. | Director | New York, NY |
| Lionel F Goldfrank, III | Promoter | New York, NY |
| Victor F Keen | Promoter | New York, NY |
| W. James F Tozer, Jr. | Promoter | New York, NY |
More